The interaction of lipophilic drugs with intestinal fatty acid-binding protein.

The interaction of lipophilic drugs with intestinal fatty acid-binding protein.

Item
http://www.wikidata.org/entity/Q30983194
The human fatty acid-binding protein family: evolutionary divergences and functionsCrystallographic study of FABP5 as an intracellular endocannabinoid transporterMolecular dynamics simulation of ligand dissociation from liver fatty acid binding proteinFunctional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studiesMillisecond timescale dynamics of human liver fatty acid binding protein: testing of its relevance to the ligand entry processA photocytes-associated fatty acid-binding protein from the light organ of adult Taiwanese firefly, Luciola cerata.Cellular and transcriptional responses of Crassostrea gigas hemocytes exposed in vitro to brevetoxin (PbTx-2).Comparative study of the fatty acid binding process of a new FABP from Cherax quadricarinatus by fluorescence intensity, lifetime and anisotropy.Preparation, crystallization and preliminary X-ray diffraction analysis of two intestinal fatty-acid binding proteins in the presence of 11-(dansylamino)undecanoic acid.Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective MannerLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.Cytotoxicity of novel fluorinated alternatives to long-chain perfluoroalkyl substances to human liver cell line and their binding capacity to human liver fatty acid binding protein.Interactions between Human Liver Fatty Acid Binding Protein and Peroxisome Proliferator Activated Receptor Selective Drugs.Letter to the Editor, Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans.Use of the harmonic mean to the determination of dissociation constants of stereoisomeric mixtures of biologically active compounds.Interaction of perfluoroalkyl acids with human liver fatty acid-binding protein.Fatty Acid Binding Proteins: Potential Chaperones of Cytosolic Drug Transport in the Enterocyte?
P2860

The interaction of lipophilic drugs with intestinal fatty acid-binding protein.

Item
http://www.wikidata.org/entity/Q30983194
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The interaction of lipophilic drugs with intestinal fatty acid-binding protein.
@ast
The interaction of lipophilic drugs with intestinal fatty acid-binding protein.
@en
type
label
The interaction of lipophilic drugs with intestinal fatty acid-binding protein.
@ast
The interaction of lipophilic drugs with intestinal fatty acid-binding protein.
@en
prefLabel
The interaction of lipophilic drugs with intestinal fatty acid-binding protein.
@ast
The interaction of lipophilic drugs with intestinal fatty acid-binding protein.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The interaction of lipophilic drugs with intestinal fatty acid-binding protein
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921